GlobeNewswire 2025-12-03 Actithera appoints radiopharmaceutical pioneer Dr. Darshan Dalal as Chief Medical Officer
GlobeNewswire 2025-12-01 AIM ImmunoTech to Participate in Live ‘Fireside’ Chat on Virtual Investor Closing Bell Series
GlobeNewswire 2025-12-01 Ascentage Pharma to Host Webcast Highlighting Key Data from ASH 2025
GlobeNewswire 2025-11-27 HUTCHMED Highlights Clinical Data to be Presented at the 2025 ESMO Asia Congress and the 2025 ASH An...
GlobeNewswire 2025-11-26 Vera Therapeutics Appoints Veteran Biotech Executive James R. Meyers to its Board of Directors
GlobeNewswire 2025-11-25 Ascentage Pharma Announces Publication of Olverembatinib Phase Ib Safety, Efficacy and Novel Mechani...
TeleTrader 2025-11-21 AstraZeneca to invest $2B in Maryland facilities
GlobeNewswire 2025-11-19 Spherix Global Insights Reports Rapidly Evolving U.S. PNH Market as Ultomiris Prescriptions Reach Pa...
GlobeNewswire 2025-11-19 Ascentage Pharma to Participate in Three Upcoming Investor Conferences in December 2025
GlobeNewswire 2025-11-14 Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights 
GlobeNewswire 2025-11-13 New Guide Helps Patients Navigate Genetic Testing for Advanced Prostate Cancer
GlobeNewswire 2025-11-12 Artelo Biosciences Provides Business Update and Reports Third Quarter 2025 Financial Results
GlobeNewswire 2025-11-10 FibroGen Reports Third Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire 2025-11-10 Voyager Reports Third Quarter 2025 Financial and Operating Results
GlobeNewswire 2025-11-10 Transition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS...
GlobeNewswire 2025-11-09 Medera Presents Late-Breaking Data from First-In-Human Gene Therapy Trial for Heart Failure with Pre...
GlobeNewswire 2025-11-07 Cellectis Reports Third Quarter 2025 Financial Results and Provides Business Update
TeleTrader 2025-11-06 Europe closes lower after BoE's decision, earnings
GlobeNewswire 2025-11-06 Novel Pipeline Activity Signals Hope in Systemic Sclerosis, as Rheumatologists Anticipate First Real...
GlobeNewswire 2025-11-06 Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics
GlobeNewswire 2025-11-06 Axsome Therapeutics Acquires Subtype Selective GABA-A Receptor Positive Allosteric Modulator AZD7325...
TeleTrader 2025-11-06 Europe opens mostly in red with BoE, earnings in focus
TeleTrader 2025-11-06 AstraZeneca’s Q3 revenue grows 12% to $15.2B
GlobeNewswire 2025-11-05 Royalty Pharma Reports Third Quarter 2025 Results
GlobeNewswire 2025-11-05 HUTCHMED Announces Enrollment Completed of SAFFRON Global Phase III Trial of ORPATHYS® and TAGRISSO®...